Cancer and comorbidity: Redefining chronic diseases

Cancer

Volumn 88, Issue 3, 2000, Pages 653-663

  Ogle, Karen S ^a   Swanson, G Marie ^b   Woods, Nancy ^c   Azzouz, Faouzi ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cancer; Chronic disease; Comorbidity; Diagnosis; Treatment

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER STAGING; COMORBIDITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SOCIAL STATUS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHRONIC DISEASE; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MICHIGAN; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PATIENT CARE PLANNING; PREVALENCE; RETROSPECTIVE STUDIES; SEER PROGRAM; SEX FACTORS; SMOKING; SOCIAL CLASS; TREATMENT OUTCOME;

EID: 0034141485     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1     Document Type: Article

References (43)

1. Sontag S. Illness as metaphor. New York: Farrar, Straus and Giroux, 1978.
2. Engle GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-36.
3. Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi WK, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996;6:399-412.
4. Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998;16:1582-7.
5. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104-10.
6. Burns PB, Swanson GM. The Occupational Cancer Incidence Surveillance Study (OCISS): risk of lung cancer by usual occupation and industry in the Detroit metropolitan area. Am J Ind Med 1991;19:655-71.
7. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical method in cancer research. Volume 1. Lyon: International Agency for Research on Cancer, 1995:192-242.
8. U.S. Department of Commerce, Bureau of the Census. 1980 Census of Population: Classified Index of Industries and Occupations. Final edition. Washington, DC: U.S. Government Printing Office, 1982.
9. Hosmer DW, Lemeshow S. Model building strategies and methods for regression. Applied logistic regression. New York: John Wiley & Sons, Inc., 1989:82-134.
10. Guralnik JM. Assessing the impact of comorbidity in the older population. Ann Epidemiol 1996;6:376-80.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40:373-83.
12. Verbrugge LM, Lepokowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q 1989;67:450-81.
13. Hoffman C, Rice D, Sung H-Y. Persons with chronic conditions: their prevalence and costs. JAMA 1996;276:1473-9.
14. Harlow SD, Linet MS. Agreement between questionnaire data and medical records: the evidence for accuracy of recall. Am J Epidemiol 1989;129:233-48.
15. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 1989;79:1554-6.
16. Horwitz RI. Comparison of epidemiologic data from multiple sources. J Chron Dis 1986;39:889-96.
17. Lloyd SS, Rissing JP. Physician and coding errors in patient records. JAMA 1985;254:1330-6.
18. National Center for Health Statistics. Net differences in interview data on chronic conditions and information derived from medical records. Vital and Health Statistics. Series 2, No. 23. Washington DC: U.S. Department of Health, Education, and Welfare, Public Health Service: 1973 DHEW Pub. No. (HSM) 73-1331.
19. Romm FJ, Putnam SM. The validity of the medical record. Med Care 1981;19:310-5.
20. Swanson GM. Cancer prevention and control: a science-based public health agenda. J Public Health Mgmt Pract 1996;2:1-8.
21. Berkman LF, Mullen JM. How health behaviors and the social environment contribute to health differences between African-American and white older Americans. In: Martin LG, Soldo BJ, editors. Racial and ethnic differences in the health of older americans. Washington, DC: National Academy Press, 1997:163-82.
22. Campbell JH, Tachas G, Black MJ, Campbell GR. Molecular biology of vascular hypertrophy. Basic Res Cardiol 1991;86: 3-11.
23. Weinberg RA. You can't get there from here: the tortuous road to basic research. Acad Med 1994;69:441-4.
24. Sporn MB, Roberts AB. Autocrine secretion - 10 years later. Ann Intern Med 1992;117:408-14.
25. Kahn BB, Flier JS. Regulation of glucose-transporter gene expression in vitro and in vivo. Diabetes Care 1990;13:548-64.
26. Isoyama S. Hypertension and age-related changes in the heart. Implications for drug therapy. Drugs Aging 1994;5: 102-15.
27. Moritz DJ, Satariano WA. Factors predicting stage of breast cancer at diagnosis in middle aged and elderly women: the role of living arrangements. J Clin Epidemiol 1993;46:443-54.
28. Mor V, Guadagnoli E, Silliman RA, Weitberg A, Glicksman A, Goldberg R, et al. Influence of old age, performance status, medical, and psychosocial status on management of cancer patients. In: Yancik R, Yates J, editors. Cancer in the elderly: approaches to early detection and treatment. New York: Springer Publishing Company, 1989:127-46.
29. Bergman L, Dekker G, van Kerkhoff EHM, Peterse HL, van Dongen JA, van Leeuwen FE. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treat 1991;18:189-98.
30. Satariano WA, Ragheb NE, Dupuis MH. Comorbidity in older women with breast cancer: an epidemiologic approach. In: Yancik R, Yates J, editors. Cancer in the elderly: approaches to early detection and treatment. New York: Springer Publishing Company, 1989:71-107.
31. Satariano WA. Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. J Gerontol 1992;47:24-31.
32. Wells CK, Stoller JK, Feinstein AR, Horwitz RI. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984;144:2004-9.
33. Greenfield S, Blanco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. JAMA 1987;257: 2766-70.
34. Greenfield S, Aronow HU, Elashoff RM, Watanabee D. Flaws in mortality data: the hazards of ignoring comorbid disease. JAMA 1988;260:2253-5.
35. Greenfield S, Aronow HU, Ganz PA, Elashoff RM. The effect of age in the management of elderly cancer patients. In: Yancik R, Yates J, editors. Cancer in the elderly: approaches to early detection and treatment. New York: Springer Publishing Company, 1989:55-70.
36. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996;88:716-26.
37. Newschaffer CJ, Penberthy L, Desch EC, Retchin SM, Whittemore M. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer. Arch Intern Med 1996;156:85-90.
38. Silliman RA, Troyan SL, Guadagnoli E, Kaplan SH, Greenfield S. The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer 1997;80:1326-4.
39. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974;27:387-404.
40. McCorkle R, Wilkerson K. Home care needs of cancer patients and their caregivers. Final report. No. NR01914. Bethesda: National Center for Nursing Research, 1991.
41. Sarna L, McCorkle R. Burden of care and lung cancer. Cancer Pract 1996;4:246-61.
42. nd Sess, September 20-22, 1966. Washington, DC: Subcommittee on the Health of the Elderly of the Special Committee on Aging, 1966:59-76.
43. Taplin SH, Barlow W, Urban N, Mandelson MT, Timlin DJ, Ichikawa L, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995;87:417-26.